KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Cost of Revenue: 2009-2024

Historic Cost of Revenue for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $1.5 billion.

  • Idexx Laboratories' Cost of Revenue rose 11.17% to $421.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 5.62%. This contributed to the annual value of $1.5 billion for FY2024, which is 3.24% up from last year.
  • Latest data reveals that Idexx Laboratories reported Cost of Revenue of $1.5 billion as of FY2024, which was up 3.24% from $1.5 billion recorded in FY2023.
  • In the past 5 years, Idexx Laboratories' Cost of Revenue registered a high of $1.5 billion during FY2024, and its lowest value of $1.1 billion during FY2020.
  • Its 3-year average for Cost of Revenue is $1.5 billion, with a median of $1.5 billion in 2023.
  • Data for Idexx Laboratories' Cost of Revenue shows a peak YoY rose of 16.76% (in 2021) over the last 5 years.
  • Over the past 5 years, Idexx Laboratories' Cost of Revenue (Yearly) stood at $1.1 billion in 2020, then increased by 16.76% to $1.3 billion in 2021, then increased by 2.79% to $1.4 billion in 2022, then climbed by 7.92% to $1.5 billion in 2023, then grew by 3.24% to $1.5 billion in 2024.